RecruitingNCT07099053

Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging

Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging (BLSA)


Sponsor

National Institute on Aging (NIA)

Enrollment

400 participants

Start Date

May 7, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

Background: Some people experience cognitive decline as they age. That is, they lose memory, problem-solving, and other mental abilities. Amyloids are groups of proteins that develop in the brain and increase in number as people age. Researchers want to use imaging scans to track amyloids in people s brains over time. Their goal is to find out if any changes are related to cognitive decline or other medical issues. Objective: To learn how amyloids may affect brain structure and function as people age. Eligibility: People aged 55 years and older who are enrolled in the Baltimore Longitudinal Study of Aging. Design: Participants will have imaging scans and other tests every 1 to 4 years, depending on their age. Those 80 and older will be scanned yearly. These scans will be done during regular BLSA visits. The scans will be positron emission tomography and computed tomography (PET CT). Participants will be given fluid through a tube inserted into a vein in their arm. The fluid is a tracer that will cause the amyloids to light up in the images. Then they will lie on a bed with their head inside a PET CT scanner. They will lie still for about 30 minutes. Participants will have tests to assess their memory and other mental skills. They will answer questions about their mood and daily life. These tests will take about 40 minutes to complete; they may be done in person or by phone. Participants will give a contact number for someone who can answer questions about the participant s daily routine. These questions may be answered in person or by phone. Participants will be in this study for 5 years.


Eligibility

Min Age: 55 YearsMax Age: 110 Years

Plain Language Summary

Simplified for easier understanding

This study is using a special brain scan called amyloid PET — which detects abnormal protein buildup linked to Alzheimer's disease — in older adults who are part of an ongoing aging research program (the Baltimore Longitudinal Study of Aging). Researchers want to understand how amyloid changes in the brain over time in healthy aging. **You may be eligible if...** - You are 55 years or older - You are already participating in the Baltimore Longitudinal Study of Aging (BLSA) - You have had or agreed to have an MRI as part of the BLSA - You are able to give informed consent **You may NOT be eligible if...** - You have a pre-existing brain or nervous system disease (e.g., Parkinson's, Huntington's, epilepsy, dementia, or mild cognitive impairment) - You weigh more than 300 lbs - You have active metastatic cancer (other than basal cell skin cancer) - You have a pacemaker, implanted hearing device, or metal implants that are unsafe for MRI - You have schizophrenia or bipolar disorder - You have poorly controlled diabetes (HbA1c above 8) - You have had a stroke requiring hospitalization - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Institute of Aging, Clinical Research Unit

Baltimore, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07099053


Related Trials